Healthcare | June 10, 2026
Remidio secures Gates Foundation grant to advance AI-powered retinal screening
Funding will support the expansion of Remidio’s Oculomics platform to identify early signs of pre-eclampsia, anemia and gestational diabetes through retinal imaging, targeting underserved communities
